IPEAX
Price
$5.52
Change
-$0.01 (-0.18%)
Updated
Apr 15 closing price
Net Assets
494.27M
RMEBX
Price
$53.58
Change
-$0.19 (-0.35%)
Updated
Apr 15 closing price
Net Assets
98.11B
Ad is loading...

IPEAX vs RMEBX

Header iconIPEAX vs RMEBX Comparison
Open Charts IPEAX vs RMEBXBanner chart's image
Voya Large Cap Value Port A
Price$5.52
Change-$0.01 (-0.18%)
VolumeN/A
Net Assets494.27M
American Funds American Mutual R2E
Price$53.58
Change-$0.19 (-0.35%)
VolumeN/A
Net Assets98.11B
IPEAX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IPEAX vs. RMEBX commentary
Apr 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPEAX is a StrongBuy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 98.1B vs. IPEAX (494M). IPEAX pays higher dividends than RMEBX: IPEAX (1.57) vs RMEBX (1.18). IPEAX was incepted earlier than RMEBX: IPEAX (18 years) vs RMEBX (11 years). IPEAX (1.48) is less costly to investors than RMEBX (1.07). IPEAX is a more actively managed with annual turnover of: 82.00 vs. RMEBX (31.00). IPEAX has a lower initial minimum investment than RMEBX: IPEAX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 4.42 vs. IPEAX (0.78). RMEBX return over 5 years is better than : 53.54 vs. IPEAX (-34.77).
IPEAXRMEBXIPEAX / RMEBX
Total Expense Ratio1.291.07121%
Annual Report Gross Expense Ratio1.481.07138%
Fund Existence18 years11 years-
Gain YTD-3.659-2.139171%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets494M98.1B1%
Annual Yield % from dividends1.571.18133%
Returns for 1 year0.784.4218%
Returns for 3 years-58.596.45-908%
Returns for 5 years-34.7753.54-65%
Returns for 10 years-48.1755.00-88%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WBS44.360.92
+2.12%
Webster Financial Corp
URGN10.750.15
+1.42%
UroGen Pharma Ltd
PNFPP24.270.22
+0.92%
Pinnacle Financial Partners
STR15.550.09
+0.58%
Sitio Royalties Corp
GALT1.34N/A
N/A
Galectin Therapeutics